Genetic

Latest Innovations

Therapeutic Agents for Treatment of Myotonic Dystrophy

 

Dr. Zimmerman's lab has developed a series of bioactive compounds for the treatment of myotonic dystrophy. The compounds disrupt the MBNL-(CUG) foci in vivo and...